2026 U.S Summer Internship: Cell Line Development Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Takeda · 4 hours ago

2026 U.S Summer Internship: Cell Line Development Intern

Takeda is a global biopharmaceutical company focused on delivering transformative medicines to patients. They are seeking a Cell Line Development Intern to gain hands-on experience in molecular and cell biology, supporting projects that contribute to Takeda’s biologics pipeline under the guidance of experienced scientists.

BiotechnologyHealth CareManufacturingMedicalPharmaceutical
badNo H1Bnote

Responsibilities

Perform molecular cloning and vector design
Prepare and validate vector constructs
Conduct CHO cell culture and transfection experiments
Draft and maintain experimental protocols and documentation
Contribute to careful record keeping, data analysis, and presentation

Qualification

Molecular cloningVector designCHO cell cultureTransfection experimentsData analysisBiology knowledgeChemistry knowledgeBiochemistry knowledgeRecord keepingPresentation skills

Required

Actively pursuing a Bachelor's or Master's degree in Biology, Chemistry, Biochemistry, or a related field
Strong foundation in biology, chemistry, and/or biochemistry
Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
Must be currently enrolled in a degree program graduating December 2026 or later
Able to work full time 40 hours a week during internship dates

Benefits

Paid sick time
Civic Duty paid time off
Participation at company volunteer events
Participation at company sponsored special events
Access to on-site fitness center (where available)
Commuter Benefit To offset your work-commute expenses, Takeda provides U.S. employees with a fixed monthly subsidy to be used for either public transportation (transit) or parking.

Company

Takeda

twittertwittertwitter
company-logo
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.

Funding

Current Stage
Public Company
Total Funding
$2.46B
2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M

Leadership Team

leader-logo
Christophe Weber
President and CEO
linkedin
leader-logo
Schuyler Fairfield
Senior Vice President, Global Head of Supply Chain
linkedin
Company data provided by crunchbase